keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Enloplatin is a carboplatin analog that has a partial role in advanced ovarian cancer.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 17,500 | |||
5 mg | 在庫あり | ¥ 41,000 | |||
10 mg | 在庫あり | ¥ 60,000 | |||
25 mg | 在庫あり | ¥ 116,500 | |||
50 mg | 在庫あり | ¥ 158,500 | |||
100 mg | 在庫あり | ¥ 225,500 | |||
500 mg | 在庫あり | ¥ 452,500 |
説明 | Enloplatin is a carboplatin analog that has a partial role in advanced ovarian cancer. |
ターゲット&IC50 | Tera (cells):7.2 µM |
In vivo | Enloplatin (i.v. infusion; over 1.5 h; every 21 days), one patient had a partial response (6%; 95% CI 0-26%) lasting 2.8 months. The median survival was 9.4 months (95%; CI 5.1-19.7%). Neutropenia was the dose-limiting toxicity. Nephrotoxicity was manageable. Enloplatin is the major form of the free drug in plasma. However, 13.5 h after initiation of treatment, 85% of the drug in plasma is protein bound. Elimination of the drug is mainly renal.[1] |
分子量 | 481.4 |
分子式 | C13H22N2O5Pt |
CAS No. | 111523-41-2 |
keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (114.25 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Enloplatin 111523-41-2 Inhibitor inhibitor inhibit